Comparison of narrow-band imaging and confocal laser endomicroscopy for the detection of neoplasia in Barrett's esophagus: A meta-analysis
Autor: | Qing Chen, Hao-Yue Hu, Min Qiu, Shu-ting Huo, Jing Ge, Shu-Juan Ma, Li-Zhi Zhou, Yi-Quan Xiong |
---|---|
Rok vydání: | 2016 |
Předmět: |
medicine.medical_specialty
Esophageal Neoplasms Cochrane Library Adenocarcinoma Gastroenterology 03 medical and health sciences Barrett Esophagus Narrow Band Imaging 0302 clinical medicine Internal medicine medicine Humans Esophagus Confocal laser endomicroscopy Microscopy Confocal Hepatology business.industry medicine.disease Confidence interval Study heterogeneity medicine.anatomical_structure Dysplasia 030220 oncology & carcinogenesis Meta-analysis Barrett's esophagus 030211 gastroenterology & hepatology Esophagoscopy business |
Zdroj: | Clinics and research in hepatology and gastroenterology. 42(1) |
ISSN: | 2210-741X |
Popis: | Summary Aims Barrett's esophagus (BE) predisposes to the development of esophageal neoplasia, including high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC). A systematic literature review and meta-analysis were performed to assess the accuracy of within-patient comparisons of narrow band imaging (NBI) and confocal laser endomicroscopy (CLE) for diagnosis of HGD/EAC in patients with BE. Methods The following databases were examined up to April 2016 without language restriction: PubMed, Embase, Medline, Web of Science and the Cochrane Library. The QUADAS-2 tool for assessing the quality of included studies was used. The meta-analysis included pooled additional detection rate (ADR), diagnostic accuracy, and 95% confidence intervals (CI). The I2 and Q-test were used to determine study heterogeneity. Results Five studies involving 251 patients, reported within-patient comparisons of NBI and CLE, were eligible for meta-analysis. Compared with NBI, pooled ADR of CLE for per-lesion detection of neoplasia in patients with BE was 19.3% (95% CI: 0.05–0.33, I2 = 74.6%). The pooled sensitivity of NBI was 62.8% (95% CI: 0.56–0.69, I2 = 94.6%), which was lower (not significantly) than that of CLE (72.3%, 95% CI: 0.66–0.78, I2 = 89.3%). The pooled specificity of NBI and CLE were similar [85.3% (95% CI: 0.84–0.87, I2 = 92.1%) vs 83.8% (95% CI: 0.82–0.85, I2 = 96.8%)]. Conclusions When compared with NBI, CLE significantly increased the per-lesion detection rate of esophageal neoplasia, HGD, and EAC in BE patients. Whether CLE is superior to NBI in neoplasia detection at per-patient level needs to be further investigated. |
Databáze: | OpenAIRE |
Externí odkaz: |